Rituximab key to survival after transplant for mantle cell lymphomaNovember 16, 2017Aggressive Lymphomas
NCI-MATCH: Nivolumab shows promising activity in noncolorectal cancersNovember 15, 2017Aggressive Lymphomas
Event-free survival at 24 months predicts outcomes in peripheral T-cell lymphomasNovember 2, 2017Aggressive Lymphomas
Adding bortezomib to R-CHOP didn’t improve survival in diffuse large B-cell lymphomaSeptember 29, 2017Aggressive Lymphomas
FDA grants accelerated approval to copanlisib for relapsed follicular lymphomaSeptember 20, 2017Aggressive Lymphomas
Biosimilar matches rituximab in large follicular lymphoma trialSeptember 12, 2017Aggressive Lymphomas
